• US stock market daily report (June 22, 2015, Monday)

    VetiGel is an algae-based polymer used to stop bleeding within seconds from the time it is applied to an open wound.

    Joe Landolina, now 22 years old, invented VetiGel when he was just 17 years old.

    Landolina, co-founder and CEO of Suneris, a biotech company that manufactures VetiGel, announced last week that they will begin shipping the gel to veterinarians inside the USA later this summer, with human use, not too far behind. Suneris plans to release the gel in Europe in Asia sometime early 2016.

    Landolina forecasts receiving FDA approval within the year for testing on human wounds. VetiGel is expected to begin being used by military personnel and Emergency Medical Technicians to treat traumatic injuries. After that, the gel will then be used in hospital operating rooms and finally consumer homes.

    He said that, if you put the tiny individual polymers together, "kind of like LEGO blocks," you can inject them into a wound site. The rollout by Suneris is a five-pack of five-milliliter syringes that costs $150. Suneris has partnered with VetPlus, a British company focused on animal medicine, to expand its manufacturing across the pond.

    Fibrin helps repair tissue over the long term and allows VetiGel not only to work fast in sealing leaks, but to actually heal the skin. Within a few minutes of application, VetiGel can be safely removed.

    VetiGel, when injected into a wound site can form a clot within 12 seconds and permanently heal the wound within minutes. Landolina said, "The fastest piece of equipment we have measures every 12 seconds, so we know that it happens in less than 12 seconds."

    Whether applied to open skin or a biopsied soft organ such as a kidney, liver or spleen, once VetiGel hits the damaged tissue, the gel instantly forms a mesh-like structure.

    Landolina said, "What that means, on the one hand, is that the gel will make a very strong adhesive that holds the wound together. But on the other hand, that mesh acts as a scaffold to help the body produce fibrin at the wound's surface."

    Contributed by Millennium Traders
About us
StockMarketsReview.com provides news coverage, analysis and researches for world stock markets, commodities and currencies. We publish articles provided by experts of leading brokerage and investment companies. At our website investors can find daily, weekly and monthly reports, news, recommendations on the IPOs and fundamental analysis for stocks which are currently traded at the stock exchange.